Immuno-oncology company Affimed to be delisted from Nasdaq after insolvency filing
UniqueMotionGraphics Clinical-stage immuno-oncology company Affimed N.V (NASDAQ:AFMD) received a written notice from the...
Tag: AFMD
Affimed shares crash after filing for the opening of insolvency proceedings
Affimed N.V. (NASDAQ:AFMD) said on Tuesday that it will file an application for opening of insolvency proceedings with the...
Affimed receives Nasdaq non-compliance notice
Affimed (NASDAQ:AFMD) has received a notice from The Nasdaq Stock Market LLC for its failure to comply with the...
Affimed stock plunges 23% on AFM24 study update
Michail_Petrov-96Shares of Affimed (NASDAQ:AFMD) plunged 23% in early trading Tuesday after the company reported updated...
Affimed reports data from mid-stage study of its lymphoma treatment
Affimed N.V. announced data from phase 2 study of the combination of acimtamig with Artiva Biotherapeutics’ allogeneic NK...
Affimed GAAP EPS of -€0.94, revenue of €0.16M
Affimed press release (NASDAQ:AFMD): Q3 GAAP EPS of -€0.94. Revenue of €0.16M (-91.8% Y/Y). As of September 30, 2024,...
Affimed Q3 2024 Earnings Preview
Affimed (NASDAQ:AFMD) is scheduled to announce Q3 earnings results on Thursday, November 14th, before market open. The...
Affimed files for $20M mixed securities shelf
Affimed (NASDAQ:AFMD) filed for $20M mixed securities shelf. This preliminary prospectus is not an offer to sell. Filing
Affimed GAAP EPS of -€1.01, revenue of €0.2M
Affimed press release (NASDAQ:AFMD): Q2 GAAP EPS of -€1.01. Revenue of €0.2M (-85.7% Y/Y). As of June 30, 2024, cash,...
Affimed Follow Up: Upcoming Acimtamig And AFM24 Updates Could Be Positive Catalysts
Summary: On 06/11/24, I published an article on Affimed focused on my belief the company’s upcoming acimtamig update...